An Overview of Therapeutic Targeting of Nrf2 Signaling Pathway in Rheumatoid Arthritis

Sarmistha Saha
DOI: https://doi.org/10.1021/acsomega.4c00163
IF: 4.1
2024-03-12
ACS Omega
Abstract:Rheumatoid arthritis (RA), an autoimmune condition that has a significant inflammatory component and is exacerbated by dysregulated redox-dependent signaling pathways. In RA, the corelationship between oxidative stress and inflammation appears to be regulated by the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway. Furthermore, it has been shown that transcriptional pathways involving Nrf2 and NFκB significantly interact under conditions of oxidative stress and inflammation....
chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the therapeutic targeting of the Nrf2 signaling pathway in rheumatoid arthritis (RA). Specifically, the paper explores the mechanism of action of the Nrf2 signaling pathway in RA and its complex relationship with oxidative stress and inflammation, and proposes potential methods for treating RA by activating Nrf2. ### 1. **Background and Problem Description** Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by significant inflammatory responses and oxidative stress. There are large amounts of reactive oxygen species (ROS) in the joints of RA patients. These ROS not only lead to oxidative stress but also further exacerbate the inflammatory response by activating multiple transcription factors (such as NFκB and Nrf2). Research shows that the Nrf2 signaling pathway plays a crucial role in regulating cellular antioxidant responses and anti - inflammatory processes. ### 2. **The Role of the Nrf2 Signaling Pathway** Nrf2 is a basic leucine zipper protein (bZIP). It forms a heterodimer with small Maf proteins in the nucleus and binds to antioxidant response elements (ARE) to initiate the expression of a series of antioxidant genes. These genes include: - Genes related to glutathione synthesis (GCLC, GCLM, GSS, xCT) - Genes related to the thioredoxin system (TRX, TRXRD1) - Antioxidant enzymes (such as catalase, glutathione peroxidase) In addition, Nrf2 is also involved in regulating cell metabolism. Especially under inflammatory conditions, it can promote the transition from oxidative phosphorylation to glycolysis, thus affecting cell survival and proliferation. ### 3. **The Interaction between Nrf2 and NFκB** There is a complex interaction between Nrf2 and NFκB. Under oxidative stress conditions, the conformational change of Keap1 (the main inhibitor of Nrf2) makes Nrf2 stable and enter the nucleus to initiate the expression of antioxidant genes. At the same time, the activation of NFκB is also affected by Nrf2. Nrf2 can help relieve inflammation by inhibiting RAC1 - dependent NFκB activation. ### 4. **Therapeutic Potential** The paper proposes that activating Nrf2 by pharmacological means may become a new strategy for treating RA. For example, some natural compounds (such as lipoic acid, quercetin, resveratrol, etc.) have been proven to be able to activate Nrf2, thereby reducing ROS generation and inflammatory responses. In addition, some synthetic compounds (such as bardoxolone methyl, omaveloxolone) are also being evaluated for their efficacy in treating RA in clinical trials. ### 5. **Future Directions** The paper also discusses future research directions, including the development of more effective Nrf2 activators and the exploration of the synergistic effects of Nrf2 with other signaling pathways. At the same time, researchers also need to further understand the specific functions of Nrf2 in different cell types to ensure its safety and effectiveness as a therapeutic target. In conclusion, this paper aims to deeply explore the mechanism of action of the Nrf2 signaling pathway in RA and provide theoretical basis and experimental support for future drug development.